5. Potential Financing Alternatives The Three Companies were: Biogen, Genentech, Amgen Generally large companies (Mkt Cap > $1B) Or those who can service the debt within 3 years Neither convertible debt nor straight debt are likely to be appropriate financing vehicles for Small Cap Biotech Companies 5